Autologous Dendritic Cell Vaccine Optimization for Therapy of Patients with Disseminated Malignant Ne

Autologous Dendritic Cell Vaccine Optimization for Therapy of Patients with Disseminated Malignant Ne

Immunobiological features of the dendritic cells (DC) were studied for the production of DC-vaccine (DCV) optimization. DC were differentiated in vitro in GM-CSF (previously studied concentration 72 ng/ml and IL-4 0–45 ng/ml containing medium. GM-CSF compounds by Pharmsynthez (Russia) and Cell Genix...

Full description

Bibliographic Details
Main Author: T. L. Nehaeva
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:Сибирский онкологический журнал
Subjects:
иммунотерапия
дендритные клетки
вакцина
оптимизация
Online Access:https://www.siboncoj.ru/jour/article/view/131

Similar Items

Similar Items